Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients

We investigated the spike IgG levels of HIV+ patients on antiretroviral therapy six months after they received their second dose (T2) and six months after the third dose (T3) of the BNT162b2 mRNA vaccine, as well as the influence of different levels of plasma HIV viremia of overall CD4+ cell count a...

Descripción completa

Detalles Bibliográficos
Autores principales: Basso, Monica, Pirola, Nicole, Pascoli, Susanna, Bragato, Beatrice, Vinci, Antonio, Iannetta, Marco, Colombo, Francesco, Geremia, Nicholas, Martignago, Luca, Rossi, Maria Cristina, Cipriani, Ludovica, Giobbia, Mario, Scotton, Pier Giorgio, Parisi, Saverio Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862719/
https://www.ncbi.nlm.nih.gov/pubmed/36679927
http://dx.doi.org/10.3390/vaccines11010082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862719/
https://www.ncbi.nlm.nih.gov/pubmed/36679927
http://dx.doi.org/10.3390/vaccines11010082

Ejemplares similares